Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - CASH FROM OPERATIONS
Cash from Operations REGN - Regeneron Pharmaceuticals, Inc.
4.42 B
LAST VALUE
-6.11%
2 YEAR CAGR
12.71%
5 YEAR CAGR
19.37%
10 YEAR CAGR